These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28585341)

  • 1. Investigation of a correlation between taxane-based chemotherapy and the ultrasonic time-of-flight of human fingernails.
    Vacarescu RA; Slak B; Maeva A; Hamm C; Lewoc N; Daabous AT; Strumban E; Maev RG
    Skin Res Technol; 2018 Feb; 24(1):20-25. PubMed ID: 28585341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
    Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
    Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
    Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
    Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology.
    Chen EI; Crew KD; Trivedi M; Awad D; Maurer M; Kalinsky K; Koller A; Patel P; Kim Kim J; Hershman DL
    PLoS One; 2015; 10(12):e0145816. PubMed ID: 26710119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxane effect in a bladder washing.
    Dustin SM; Jeffus SK; Stelow EB
    Diagn Cytopathol; 2015 Jan; 43(1):32-3. PubMed ID: 24644138
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic polymorphisms of lysophosphatidic acid receptor 1 are associated with the onset of taxane-induced peripheral neuropathy.
    Tsuchida R; Tanabe Y; Nishizawa D; Ikeda K; Abe H; Inoue R; Kurano M; Yatomi Y; Tamura K; Takano T; Shimizu C; Uchida K; Sumitani M
    Br J Anaesth; 2021 Aug; 127(2):e43-e46. PubMed ID: 34024637
    [No Abstract]   [Full Text] [Related]  

  • 7. Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.
    Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB
    Support Care Cancer; 2020 Sep; 28(9):4459-4466. PubMed ID: 31925531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
    Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
    Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM1 for taxane-induced neuropathy in breast cancer.
    Das M
    Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Identification of biomarkers and new therapies for taxane-induced peripheral neuropathy].
    Koyanagi M; Imai S; Nakagawa T; Matsubara K
    Nihon Yakurigaku Zasshi; 2019; 154(5):241-244. PubMed ID: 31735751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A; Dogan M; Artuz F; Zengin N
    Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug evaluation: Bay-59-8862.
    Eckstein JW
    IDrugs; 2004 Jun; 7(6):575-81. PubMed ID: 15197663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lafutidine, a histamine H2-receptor antagonist, for taxane-induced peripheral neuropathy in patients with gynecological malignancies.
    Nagano H; Sanai H; Muraoka M; Takagi K
    Gynecol Oncol; 2012 Oct; 127(1):172-4. PubMed ID: 22750259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study.
    Kus T; Aktas G; Kalender ME; Sevinc A; Kul S; Suner A; Ulker E; Camci C
    Support Care Cancer; 2016 Mar; 24(3):1175-9. PubMed ID: 26279147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
    Fontes F; Pereira S; Castro-Lopes JM; Lunet N
    Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
    Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
    Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
    Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
    Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy: A Brief Report.
    Ben-Arye E; River Y; Keshet Y; Lavie O; Israeli P; Samuels N
    Int J Gynecol Cancer; 2018 Jun; 28(5):1045-1049. PubMed ID: 29561303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab.
    Jones LW; Haykowsky M; Peddle CJ; Joy AA; Pituskin EN; Tkachuk LM; Courneya KS; Slamon DJ; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1026-31. PubMed ID: 17507633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and results of a test dose program with taxanes.
    Krieger JA; Stanford BL; Ballard EE; Rabinowitz I
    Cancer J; 2002; 8(4):337-41. PubMed ID: 12184412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.